MedTrace Logo

Muscle Ageing Sarcopenia Study Lifecourse (MASS Lifecourse)

NCT04239495 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2020-01-27

No results posted yet for this study

Summary

Sarcopenia is the loss of muscle mass and function with age. It has been recognised as an important health problem because it is common in older adults and associated with decline in physical function as well as a reduced quality of life. Sarcopenia can also lead to serious health consequences in terms of increased disability and the need for increased health and social care.

There is considerable interest in understanding what causes sarcopenia in order to develop new approaches to prevention, diagnosis and treatment. To gain a detailed understanding of sarcopenia across a range of ages, we have designed the Muscle Ageing Sarcopenia Study (MASS\_Lifecourse) in collaboration with members of the public and patients.

Conditions

Interventions

OTHER

Observational study: range of clinical and lifestyle factors

Medical conditions and medications. Educational and occupational history. Lifestyle exposures, assessed using reduced Food Frequency Questionnaire, Rapid Assessment of Physical Activity questionnaire and objectively-measured physical activity levels over 7 days using a GeneActiv wrist-worn accelerometer (Activinsights, Cambridge, UK).

Sponsors & Collaborators

  • Newcastle-upon-Tyne Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Richard M Dodds, MBBS PhD · Newcastle University

  • Avan A Sayer, PhD FRCP · Newcastle University

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2020-10-01
Completion
2021-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04239495 on ClinicalTrials.gov